II
ADMA icon

Inspire Investing’s ADMA Biologics ADMA Stock Holding History

Inspire Investing’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$677K Buy
80,854
+24,456
+43% +$223K 0.03% 807
2026
Q1 		$508K Buy
56,398
+30,722
+120% +$485K 0.03% 824
2025
Q4 		$468K Sell
25,676
-5,638
-18% -$95K 0.04% 477
2025
Q3 		$459K Buy
31,314
+10,132
+48% +$174K 0.04% 392
2025
Q2 		$386K Buy
21,182
+3,742
+21% +$76.3K 0.04% 701
2025
Q1 		$346K Sell
17,440
-6,051
-26% -$105K 0.04% 380
2024
Q4 		$403K Sell
23,491
-41,176
-64% -$775K 0.05% 428
2024
Q3 		$1.29M Buy
64,667
+32,645
+102% +$508K 0.13% 159
2024
Q2 		$358K Sell
32,022
-157,281
-83% -$1.32M 0.04% 373
2024
Q1 		$1.25M Buy
189,303
+105,256
+125% +$575K 0.13% 195
2023
Q4 		$380K Sell
84,047
-2,276
-3% -$8.42K 0.04% 769
2023
Q3 		$309K Sell
86,323
-62,663
-42% -$241K 0.04% 443
2023
Q2 		$550K Sell
148,986
-14,196
-9% -$52.6K 0.07% 279
2023
Q1 		$540K Buy
+163,182
New +$564K 0.07% 215

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Inspire Investing's ADMA Position: Q2 2026 in Review

Inspire Investing increased its ADMA Biologics (ADMA) stake by 43% in Q2 2026, buying an estimated $223K and bringing the position to 80,854 shares worth $677K. The position accounts for 0.03% of the portfolio, ranked #807.

Inspire Investing first reported a position in ADMA in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.29M in Q3 2024. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Inspire Investing held 80,854 shares of ADMA Biologics worth $677K as of Q2 2026.
  • Inspire Investing bought 24,456 ADMA Biologics shares in Q2 2026, an estimated $223K.
  • ADMA Biologics made up 0.03% of Inspire Investing's portfolio in Q2 2026, its #807 holding.
  • Inspire Investing first reported a position in ADMA Biologics in Q1 2023 and has held it in 14 quarters since.
  • Inspire Investing's ADMA Biologics position peaked at $1.29M in Q3 2024.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.